This inventor holds 2 USPTO granted patents. Top assignee: Kali-Chemie Pharma Gmbh. Active years: 1987-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- St. Trivier sur Moignans, FR (1987)
- Trivier sur Moignans, FR (1992)
Company Filing History:
Years Active: 1987-1992
Title: The Innovative Contributions of Dominique Biard
Introduction
Dominique Biard is a notable inventor based in Trivier sur Moignans, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic properties. With a total of 2 patents, his work has garnered attention in the scientific community.
Latest Patents
Biard's latest patents include innovative compounds such as 1,2-dithiol-3-thion-S-oxide compounds and pharmaceutical compositions. These compounds are utilized as active substances in hepato-protective medicaments. His research also focuses on new 5-phenyl-3H-1,2-dithiol-3-thion-S-oxides, which are substituted in the phenyl ring. Additionally, he has developed antiallergic 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-one compounds. These compounds exhibit pharmacological properties, particularly in the realm of allergy treatment.
Career Highlights
Dominique Biard is currently associated with Kali-Chemie Pharma GmbH, where he continues to innovate and contribute to pharmaceutical research. His work is characterized by a commitment to developing new therapeutic agents that address various health issues.
Collaborations
Throughout his career, Biard has collaborated with esteemed colleagues such as Daniel Jasserand and Marie-Odile Christen. These partnerships have enhanced the scope and impact of his research.
Conclusion
Dominique Biard's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic compounds that may improve health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile